Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6429686 | 0.81 | CYP2C19 (0.37) | CYP2C19HIF1ATAAR1 | |
| SCHEMBL5526988 | 0.78 | CYP2C19 (0.41) | RIPK1CYP2C19HIF1ATAAR1 | |
| SCHEMBL6430080 | 0.78 | CYP2C19 (0.36) | CYP2C19HIF1ATAAR1 | |
| SCHEMBL10264390 | 0.76 | CYP2C19 (0.39) | RIPK1CYP2C19HIF1ATAAR1 | |
| SCHEMBL6180685 | 0.75 | RIPK1 (0.44) | RIPK1CYP2C19HIF1ATAAR1 | |
| SCHEMBL5518734 | 0.74 | CYP2C19 (0.40) | RIPK1CYP2C19HIF1ATAAR1 | |
| SCHEMBL6505272 | 0.73 | CYP2C19 (0.39) | RIPK1CYP2C19HIF1ATAAR1 | |
| SCHEMBL13106114 | 0.72 | RIPK1 (0.42) | RIPK1CYP2C19HIF1ATAAR1 | |
| SCHEMBL6180287 | 0.71 | ACACB (0.45) | RIPK1CYP2C19HIF1ATAAR1 | |
| SCHEMBL19176126 | 0.71 | ACACB (0.45) | RIPK1CYP2C19HIF1ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005047236-A1 | SULFOXIDE AND BIS-SULFOXIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | ESPERION THERAPEUTICS, INC. (US) | 2005-05-26 | — | — | WO | disclosed |
| EP-1366024-A2 | SULFOXIDE AND BIS-SULFOXIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | Esperion Therapeutics Inc. (US) | 2003-12-03 | — | — | EP | disclosed |
| WO-2002030882-A2 | SULFOXIDE AND BIS-SULFOXIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | ESPERION THERAPEUTICS, INC. (US) | 2002-04-18 | — | — | WO | disclosed |